Welcome!

iPhone Authors: Jayaram Krishnaswamy, Jnan Dash, PR.com Newswire, Shelly Palmer, Kevin Benedict

News Feed Item

Researches on Top Movers: Facebook, Apple, Pfizer, American International Group, Hewlett-Packard, and Wells Fargo

VANCOUVER, British Columbia, Dec. 27, 2012 /PRNewswire/ -- Insiderslab.com has issued insider trading reports and equity research for the following companies: Facebook (NASDAQ:FB), Apple (NASDAQ:AAPL), Pfizer (NYSE:PFE), American International Group (NYSE:AIG), Hewlett-Packard (NYSE:HPQ), and Wells Fargo (NYSE:WFC).

(Logo: http://photos.prnewswire.com/prnh/20100419/HKM001LOGO )

(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)

Report Highlights:

Facebook Inc. (NASDAQ:FB): Insiderslab.com found Facebook Inc. (NASDAQ:FB) Vice President - Engineering, Michael Schroepfer, sold 55,000 shares on December 17, at stock price US$26.79 for about US$1.47 million. Additionally, Sheryl K. Sandberg, Chief Operating Officer, Director, totally cashed out for about US$2.08 million on December 18 in two separate transactions. Academic studies have shown that company insiders traditionally make higher investment returns than ordinary investors. Do you want to know when company insiders will purchase their shares?

Read Full Report: http://www.insiderslab.com/PR3/122712A/FB/Facebook.pdf

Apple Inc. (NASDAQ:AAPL): Between September 25 and December 24, Apple Inc. (NASDAQ:AAPL) officials have sold US$52.54 million in shares, while others have purchased US$1.00 million worth. Apple announced that its iPhone 5 has been sold over two million in China, within three days since its launch on December 14. Insiderslab.com refers insider trading data to professional investors since company insiders have better access to company non-public information. See insider trade report for AAPL here.

Read Full Report: http://www.insiderslab.com/PR3/122712A/AAPL/Apple.pdf

Pfizer Inc. (NYSE:PFE): Halozyme Therapeutics, Inc. announced on December 21 that it has entered into a worldwide Collaboration and License Agreement with Pfizer Inc. (NYSE:PFE) to develop injectable versions of the drugmaker's biotech drugs. Moreover, Pfizer recently approved a US$0.24 first-quarter 2013 dividend on the company's common stock, payable March 5, 2013, to shareholders of record on February 1, 2013. Do you think now is a good time to buy or sell the stock? Do you want to know when Pfizer insiders will purchase their shares? See insider trade report for PFE here.

Read Full Report: http://www.insiderslab.com/PR3/122712A/PFE/Pfizer.pdf

Today Insiderslab.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.

American International Group, Inc. (NYSE:AIG):

Read Full Report: http://www.insiderslab.com/PR3/122712A/AIG/AmericanInternationalGroup.pdf

Hewlett-Packard Company (NYSE:HPQ):

Read Full Report: http://www.insiderslab.com/PR3/122712A/HPQ/HewlettPackard.pdf

Wells Fargo & Company (NYSE:WFC):

Read Full Report: http://www.insiderslab.com/PR3/122712A/WFC/WellsFargo.pdf

Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.

About Insiderslab.com:

Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore.  Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.

Important Disclaimer:
Please visit insiderslab.com/disclaimers/disclaimers.php for details. 

SOURCE Insiderslab.com; Insiders.hk

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.